Search Results - V G Chasnyk
- Showing 1 - 12 results of 12
-
1
The level of anxiety and depression in children and adolescents with chronic pain syndrome (on the example of juvenile idiopathic arthritis) by A. V. Santimov, V. G. CHasnyk, S. V. Grechanyi
Published 2020-01-01In order to study the effect of anxiety and depression on the severity of chronic pain syndrome, 216 patients with the diagnosis of juvenile idiopathic arthritis (JIA) were examined. All children included in the study underwent a traditional rheumatological examination, with an assessment of the dis...
Get full text
Article -
2
MODERN APPROACHES TO THERAPY FOR CHILDREN WITH MUCOPOLYSACCHARIDOSIS by N. V. Buchinskaya, I. А. Chikova, E. А. Isupova, О. V. Kalashnikova, М. М. Kostik, V. G. Chasnyk
Published 2014-05-01Mucopolysaccharidosis is the group of hereditary metabolic disorders; it is characterized by accumulation of glycosaminoglycans owing to storage of specific lysosomal enzymes. Background: Research objective was to study the influence of enzyme replacement therapy on a somatic state and psychomotor d...
Get full text
Article -
3
How to identify a patient with autoinflammatory syndrome: Clinical and diagnostic algorithms by Mikhail Mikhailovich Kostik, L S Snegireva, M F Dubko, V V Masalova, T S Likhacheva, O V Kalashnikova, V G Chasnyk
Published 2013-10-01Autoinflammatory syndromes (AISs) are a group of predominantly hereditary diseases associated with the spontaneous uncontrolled production of proinflammatory cytokines. Most diseases are known to have molecular mechanisms and an inheritance pattern. The paper describes major AISs, such as familial M...
Get full text
Article -
4
FARBER DISEASE — DISEASE DESCRIPTION WITH CASE REPORTS by I. A. Chikova, N. V. Buchinskaya, М. М. Kostik, V. V. Avramenko, O. L. Krasnogorskaya, R. A. Nasirov, T. Levade, V. G. Chasnyk
Published 2014-12-01Farber disease (lipogranulomatosis, OMIM 228000) — is extremely rare autosomal-recessive disorder from group of lysosomal storage disorders, due to deficiency of acid ceramidase activity enzyme. Farber disease has a lot of clinical masques and resembles to different inflammatory disorders, such as j...
Get full text
Article -
5
Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up by M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
Published 2018-01-01Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy was initiated because of the inefficiency of using...
Get full text
Article -
6
Current approaches to diagnosing and treating macrophage activation syndrome in children with rheumatic diseases by M. M. Kostik, M. F. Dubko, V. V. Masalova, L. S. Snegireva, I. A. Chikova, E. A. Isupova, O. V. Kalashnikova, V. G. Chasnyk
Published 2015-03-01Macrophage activation syndrome (MAS) is a severe life-threatening complication presenting with hemophagocytosis, pancytopenia, coagulopathy, and liver and CNS dysfunctions. The disease belongs to a group of histiocytic disorders. The common triggers for MAS are rheumatic diseases, particularly syste...
Get full text
Article -
7
NLRP12-associated periodic syndrome: A description of the authors' own observation and an analysis of literature data by M. F. Dubko, E. N. Suspitsyn, A. P. Sokolenko, E. N. Imyanitov, T. S. Likhacheva, A. Yu. Kazantseva, O. V. Kalashnikova, V. G. Chasnyk, M. M. Kostik
Published 2017-04-01Autoinflammatory diseases (AIDs) are a group of rare disorders characterized by persistent or recurrent inflammation caused by the hyperactivation of mediators and innate immune cells (neutrophils, monocytes/macrophages). The paper describes the authors' own case of NLRP12-associated AIDs and t...
Get full text
Article -
8
The Efficiency of Adalimumab in Cases of Chronic Methotrexate-Resistant Juvenile Idiopathic Arthritis-Associated Anterior Uveitis: Retrospective Case Series Study by E. V. Gaidar, M. M. Kostik, M. F. Dubko, V. V. Masalova, L. S. Snegireva, E. A. Isupova, T. N. Nikitina, E. D. Serogodskaya, O. V. Kalashnikova, V. G. Chasnyk
Published 2016-11-01Background: Juvenile idiopathic arthritis (JIA) associated uveitis may be the cause of not only visual acuity decrement, but also blindness. At the same time, in some patients therapy with methotrexate can not prevent the development of these complications.Objective: Our aim was to investigate the e...
Get full text
Article -
9
Can the Methotrexate Therapy Prevent the Development of Uveitis in Patients with Juvenile Idiopathic Arthritis: Results of a Retrospective Study by M. M. Kostik, E. V. Gaydar, M. F. Dubko, V. V. Masalova, L. S. Snegireva, I. A. Chikova, E. A. Isupova, T. N. Nikitina, E. D. Serogodskaya, O. V. Kalashnikova, A. Ravelli, V. G. Chasnyk
Published 2015-09-01Background: Uveitis is one of the most common extra-articular manifestations of juvenile idiopathic arthritis (JIA). Currently, the possibility of reducing the risk of uveitis in children with JIA by using methotrexate has been studied.Objective: Our aim was to analyze the results of treatment of ch...
Get full text
Article -
10
PACHYDERMODACTYLY IN A RHEUMATOLOGIST'S PRACTICE by I. A. Chikova, M. M. Kostik, E. V. Sinelnikova, M. F. Dubko, O. I. Krasnogorskaya, A. I. Imelbaev, R. N. Polozov, N. V. Buchinskaya, E. A. Isupova, E. V. Gaidar, O. V. Kalashnikova, R. A. Nasyrov, V. G. Chasnyk
Published 2015-09-01Pachydermodactyly is a rare form of fibromatosis, which is characterized by an asymptomatic soft tissue enlargement around the proximal interphalangeal (PIP) joints of the hand. The etiology of the disease is unknown. Its possible triggers are recurrent minimal trauma, a habit or compulsive need to...
Get full text
Article -
11
Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series by M. Yu. Rykov, I. V. Filinov, E. I. Petrov, N. D. Vashakmadze, A. K. Gevorkyan, E. N. Arkhipova, I. V. Sil’nova, E. N. Basargina, N. V. Buchinskaya, A. I. Ivanov, E. A. Isupova, M. M. Kostik, N. A. Abramova, O. V. Kalashnikova, V. G. Chasnyk, A. E. Aleksandrov, D. A. Morozov, V. G. Polyakov
Published 2015-09-01Many orphan diseases in children require life-long and regular intravenous enzyme replacement therapy. The article describes the first Russian practice of implanting venous port systems in 12 patients with type I and II mucopolysaccharidosis and Pompe disease (6 months to 17 years old) to create lon...
Get full text
Article -
12
Experience in the diagnosis and treatment of Kawasaki disease in the Saint-Petersburg State Pediatric Medical University Clinic and Saint Petersburg City Children’s Hospital One by A. V. Santimov, R. A. Rupp, I. G. Alekseev, N. N. Plutova, E. A. Moskvina, M. K. Kruchina, A. N. Tarasenko, N. E. Sokolova, E. A. Savelyeva, I. Yu. Bogdanov, D. V. Ivanov, T. I. Kandrina, O. V. Kopanevich, A. Ya. Grafskaya, N. A. Ignatyeva, D. B. Pulukchu, N. V. Pavlova, I. V. Solodkova, O. V. Kalashnikova, T. L. Kornishina, M. F. Dubko, V. G. Chasnyk, M. M. Kostik
Published 2017-09-01Kawasaki disease (KD) is acute systemic vasculitis of unknown etiology. Approximately 20–25% of untreated patients develop coronary artery changes with a range of severity from asymptomatic coronary artery dilatation to giant coronary artery aneurysms with thrombosis, myocardial infarction, and sudd...
Get full text
Article